About Ultrasight
Ultrasight is a healthcare AI company dedicated to revolutionizing cardiac care by making diagnostic imaging more accessible and efficient. Their core offering is an AI-driven software that provides real-time guidance and quality assessment for cardiac ultrasound examinations. This technology empowers a broad range of healthcare professionals, regardless of their prior sonography experience, to consistently acquire high-quality cardiac ultrasound images at the point of care, including clinics, community hospitals, ambulances, and remote settings.
The company’s solution addresses the critical need for earlier diagnosis and treatment of cardiovascular diseases, which remain a leading cause of mortality globally. By simplifying the process of cardiac sonography, Ultrasight aims to overcome the challenges of traditional workflows, such as delays and limited access to specialized expertise, thereby accelerating clinical decision-making and improving patient outcomes. Ultrasight’s software has received FDA 510(k) Clearance, UKCA, CE Mark, and Israeli AMAR Clearance, demonstrating its regulatory compliance and readiness for broader clinical adoption.
Focus Areas
Business Intelligence
| Key Investors | The Yozma Group Korea, Atain Specialty Insurance Company, Weizmann Institute of Science, Mayo Clinic Ventures, Endless Frontier Labs, American Society of Echocardiography, Iron Nation Fund, Johnson & Johnson JJDC |
| Partnerships | Mayo Clinic, SELVAS Healthcare, EchoNous, Butterfly Network (Butterfly Garden), American Society of Echocardiography (ASE Accelerator Program), Jefferson Health, GE Healthcare |
| Acquisitions | None |
| Technology | Deep learning-based Real-Time Guidance software, AI-driven software for real-time guidance and quality assessment, geometrical deep learning AI. Integrates with healthcare IT standards such as PACS, FHIR, EMR/EHR, and DICOM. |
| FDA Clearances | 3 cleared products (estimated) |
What Physicians Need to Know
Ultrasight's AI-guided ultrasound system is a game-changer for physicians seeking to enhance cardiac care. It empowers a wider range of medical professionals, including those without extensive sonography experience, to acquire diagnostic-quality cardiac images efficiently at the point of care. This leads to faster diagnoses, earlier interventions, and improved patient outcomes, especially in settings with limited access to specialists. The real-time guidance reduces variability in image acquisition, standardizes workflows, and can significantly reduce the need for repeat imaging, thereby improving operational efficiency and allowing cardiologists to focus on complex cases and interpretations. It also supports scalable screening programs for prevalent conditions like heart failure and structural heart disease.
Ultrasight's AI guidance software is designed as an accessory to compatible general-purpose diagnostic ultrasound systems, including handheld, laptop, and cart-based systems. It has been shown to be compatible with devices like the Philips Lumify Ultrasound System and GE Healthcare's handheld GE Vscan Air. The company is actively working on integrating healthcare IT standards such as PACS, FHIR, EMR/EHR, or DICOM into its products to ensure seamless workflow integration within existing clinical infrastructures.
Reviews & Opinions
Videos
News, demos, and interviews about Ultrasight.
Videos load interactively. If none appear, search YouTube for Ultrasight →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]